N6-methyladenosine (m6A) modification, a dynamic and reversible post-transcriptional RNA alteration, plays a critical role in the precise regulation of gene expression and is fundamentally implicated in the interplay between tumor cells and the immune system. This review focuses on the regulatory mechanisms of m6A methylation in tumor immunology. We examine how m6A modifications within tumor cells reprogram the tumor immune microenvironment by modulating immune checkpoints, canonical signaling pathways, and cytokine secretion, as well as directly regulating immune-related genes. Crucially, we also dissect how m6A modification within immune cells shapes the immune microenvironment. Furthermore, we propose novel therapeutic strategies combining m6A targeting with immunotherapy. Collectively, this review provides novel insights into the role of m6A methylation in tumor immunology and paves the way for future research directions.